Microbiome sequencing: challenges and opportunities for molecular medicine

Expert Review of Molecular Diagnostics

Volumn 16, Issue 7, 2016, Pages 795-805

  Clavel, Thomas ^a   Lagkouvardos, Ilias ^a   Hiergeist, Andreas ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

16S rRNA gene; clinical microbiology; Complex microbial communities; gut microbiome; metagenomics; molecular diagnostics; sequencing

Indexed keywords

RNA 16S; BACTERIAL DNA;

AMPLICON; ANTIBIOTIC RESISTANCE; BIOINFORMATICS; CHRONIC DISEASE; FECAL MICROBIOTA TRANSPLANTATION; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; INTESTINE FLORA; LACHNOSPIRACEAE; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; MOLECULAR MEDICINE; NONHUMAN; PORPHYROMONADACEAE; REVIEW; RUMINOCOCCACEAE; CHEMISTRY; DNA SEQUENCE; GENETICS; HUMAN; MOLECULAR DIAGNOSIS; MOLECULAR TYPING; PROCEDURES; STANDARDS;

DNA, BACTERIAL; GASTROINTESTINAL MICROBIOME; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR TYPING; SEQUENCE ANALYSIS, DNA;

EID: 84975503294     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1080/14737159.2016.1184574     Document Type: Review

References (101)

1. P.E.Fournier, M.Drancourt, P.Colson, et al. Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol. 2013;11(8):574–585.
2. J.R.Marchesi, J.Ravel The vocabulary of microbiome research: a proposal. Microbiome. 2015;3:31.
3. A.Croxatto, G.Prod’hom, G.Greub. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012;36(2):380–407.
4. M.J.Suhr, H.E.Hallen-Adams. The human gut mycobiome: pitfalls and potentials-a mycologist’s perspective. Mycologia. 2015;107(6):1057–1073.
5. H.W.Virgin. The virome in mammalian physiology and disease. Cell. 2014;157(1):142–150.
6. S.J.Heerema, C.Dekker. Graphene nanodevices for DNA sequencing. Nat Nanotechnol. 2016;11(2):127–136.
7. M.L.Metzker. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11(1):31–46.
8. J.R.Cole, Q.Wang, J.A.Fish, et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42(Database issue):D633–642.
9. H.F.Noller, C.R.Woese. Secondary structure of 16S ribosomal RNA. Science. 1981;212(4493):403–411.
10. C.Quast, E.Pruesse, P.Yilmaz, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590–596.
11. E.A.Franzosa, K.Huang, J.F.Meadow, et al. Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci U S A. 2015;112(22):E2930–2938.
12. K.Forslund, F.Hildebrand, T.Nielsen, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528(7581):262–266.• This paper draws attentation to the importance of phenotyping human cohort in a thorough manner to avoid misleading conclusions with respect to shifts in fecal microbiota associated with a specific disease.
13. C.Manichanh, L.Rigottier-Gois, E.Bonnaud, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut. 2006;55(2):205–211.
14. G.Zeller, J.Tap, A.Y.Voigt, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10:766.
15. A.J.Macpherson, K.D.McCoy. Standardised animal models of host microbial mutualism. Mucosal Immunol. 2015;8(3):476–486.
16. M.Schaubeck, T.Clavel, J.Calasan, et al. Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis independent of failure in antimicrobial defence. Gut. 2015;65(2):225–237.
17. M.I.Smith, T.Yatsunenko, M.J.Manary, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339(6119):548–554.
18. E.O.Petrof, G.B.Gloor, S.J.Vanner, et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome. 2013;1(1):3.
19. E.Van Nood, A.Vrieze, M.Nieuwdorp, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–415.•• Papers 18 and 19 illustrate successful clinical utilization of complex fecal microbiota or a mixture of cultured bacteria for treatment of Clostridium difficile infection.
20. J.Quick, P.Ashton, S.Calus, et al. Rapid draft sequencing and real-time nanopore sequencing in a hospital outbreak of Salmonella. Genome Biol. 2015;16:114.
21. J.Quick, N.J.Loman, S.Duraffour, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530(7589):228–232.
22. N.J.Loman, C.Constantinidou, M.Christner, et al. A culture-independent sequence-based metagenomics approach to the investigation of an outbreak of Shiga-toxigenic Escherichia coli O104:H4. JAMA. 2013;309(14):1502–1510.•• Papers 20–22 show concrete applications of next generation sequencing technologies in the context of pathogen outbreaks.
23. H.B.Nielsen, M.Almeida, A.S.Juncker, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol. 2014;32(8):822–828.
24. S.Greenblum, R.Carr, E.Borenstein. Extensive strain-level copy-number variation across human gut microbiome species. Cell. 2015;160(4):583–594.
25. J.J.Faith, J.L.Guruge, M.Charbonneau, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439.
26. N.P.McNulty, T.Yatsunenko, A.Hsiao, et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 2011;3(106):106ra106.
27. R.Sinha, C.C.Abnet, O.White, et al. The microbiome quality control project: baseline study design and future directions. Genome Biol. 2015;16:276.
28. A.Hiergeist, J.Glasner, U.Reischl, et al. Analyses of intestinal microbiota: culture versus sequencing. ILAR J /National Res Council Inst Lab Anim Resour. 2015;56(2):228–240.•• Papers 27 and 28 address important issues on the need for standardization pertaining to the study of complex microbial communities by sequencing.
29. M.Valles-Colomer, Y.Darzi, S.Vieira-Silva, et al. Meta-omics in IBD research: applications, challenges and guidelines. J Crohns Colitis. 2016;jjw024.
30. C.Dominianni, J.Wu, R.B.Hayes, et al. Comparison of methods for fecal microbiome biospecimen collection. BMC Microbiol. 2014;14:103.
31. A.Santiago, S.Panda, G.Mengels, et al. Processing faecal samples: a step forward for standards in microbial community analysis. BMC Microbiol. 2014;14:112.
32. L.Cuthbertson, G.B.Rogers, A.W.Walker, et al. Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses. J Cyst Fibros. 2015;14(4):464–467.
33. S.Cardona, A.Eck, M.Cassellas, et al. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol. 2012;12:158.
34. I.M.Carroll, T.Ringel-Kulka, J.P.Siddle, et al. Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One. 2012;7(10):e46953.
35. L.F.Roesch, G.Casella, O.Simell, et al. Influence of fecal sample storage on bacterial community diversity. Open Microbiol J. 2009;3:40–46.
36. J.S.Weese, M.Jalali. Evaluation of the impact of refrigeration on next generation sequencing-based assessment of the canine and feline fecal microbiota. BMC Vet Res. 2014;10:230.
37. L.Cuthbertson, G.B.Rogers, A.W.Walker, et al. Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infections. J Clin Microbiol. 2014;52(8):3011–3016.
38. A.W.Walker, J.C.Martin, P.Scott, et al. 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome. 2015;3:26.
39. R.Bonnet, A.Suau, J.Dore, et al. Differences in rDNA libraries of faecal bacteria derived from 10- and 25-cycle PCRs. Int J Syst Evol Microbiol. 2002;52(Pt 3):757–763.
40. J.Y.Wu, X.T.Jiang, Y.X.Jiang, et al. Effects of polymerase, template dilution and cycle number on PCR based 16 S rRNA diversity analysis using the deep sequencing method. BMC Microbiol. 2010;10:255.
41. J.G.Caporaso, J.Kuczynski, J.Stombaugh, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336.
42. R.C.Edgar. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998.
43. D.H.Huson, A.F.Auch, J.Qi, et al. MEGAN analysis of metagenomic data. Genome Res. 2007;17(3):377–386.
44. P.D.Schloss, S.L.Westcott, T.Ryabin, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–7541.
45. H.P.Browne, S.C.Forster, B.O.Anonye, et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature. 2016 May 4. doi:10.1038/nature17645• This paper highlights the importance of combining molecular and culture-based techniques for proper investigation of complex microbial ecosystems such as the gut microbiota.
46. A.L.Goodman, G.Kallstrom, J.J.Faith, et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A. 2011;108(15):6252–6257.
47. P.A.Lawson, F.A.Rainey. Proposal to restrict the genus Clostridium (Prazmowski) to Clostridium butyricum and related species. Int J Syst Evol Microbiol. 2016;66:1009–1016.
48. R.Sender, S.Fuchs, R.Milo. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell. 2016;164(3):337–340.
49. J.C.Lagier, F.Armougom, M.Million, et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect. 2012;18(12):1185–1193.
50. M.Rajilic-Stojanovic, W.M.De Vos. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38(5):996–1047.
51. F.Backhed, R.E.Ley, J.L.Sonnenburg, et al. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915–1920.
52. P.B.Eckburg, E.M.Bik, C.N.Bernstein, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–1638.
53. D.N.Frank, A.L.St Amand, R.A.Feldman, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780–13785.
54. W.E.Moore, L.V.Holdeman. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol. 1974;27(5):961–979.
55. J.Qin, R.Li, J.Raes, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65.
56. A.Suau, R.Bonnet, M.Sutren, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. 1999;65(11):4799–4807.
57. J.Tap, S.Mondot, F.Levenez, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009;11(10):2574–2584.
58. D.Vandeputte, G.Falony, S.Vieira-Silva, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65(1):57–62.
59. C.C.Booijink, S.El-Aidy, M.Rajilic-Stojanovic, et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol. 2010;12(12):3213–3227.
60. R.D’Amore, U.Z.Ijaz, M.Schirmer, et al. A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling. BMC Genomics. 2016;17(1):55.
61. S.Sontakke, M.B.Cadenas, R.G.Maggi, et al. Use of broad range16S rDNA PCR in clinical microbiology. J Microbiol Methods. 2009;76(3):217–225.
62. L.Garcia-Alvarez, M.T.Holden, H.Lindsay, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011;11(8):595–603.
63. D.A.Rasko, D.R.Webster, J.W.Sahl, et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med. 2011;365(8):709–717.
64. S.Reuter, M.J.Ellington, E.J.Cartwright, et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med. 2013;173(15):1397–1404.
65. R.K.Aziz, D.Bartels, A.A.Best, et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 2008;9:75.
66. V.M.Markowitz, I.M.Chen, K.Palaniappan, et al. IMG: the integrated microbial genomes database and comparative analysis system. Nucleic Acids Res. 2012;40(Database issue):D115–122.
67. A.G.McArthur, N.Waglechner, F.Nizam, et al. The comprehensive antibiotic resistance database. Antimicrob Agents Chemother. 2013;57(7):3348–3357.
68. C.U.Koser, M.J.Ellington, E.J.Cartwright, et al. Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog. 2012;8(8):e1002824.
69. J.C.Kwong, N.McCallum, V.Sintchenko, et al. Whole genome sequencing in clinical and public health microbiology. Pathology. 2015;47(3):199–210.
70. B.Shi, M.Chang, J.Martin, et al. Dynamic changes in the subgingival microbiome and their potential for diagnosis and prognosis of periodontitis. MBio. 2015;6(1):e01926–01914.
71. J.P.Zackular, M.A.Rogers, M.T.Ruffin, et al. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila). 2014;7(11):1112–1121.
72. A.Cotillard, S.P.Kennedy, L.C.Kong, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013;500(7464):585–588.
73. F.H.Karlsson, V.Tremaroli, I.Nookaew, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103.
74. E.Le Chatelier, T.Nielsen, J.Qin, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–546.
75. J.Qin, Y.Li, Z.Cai, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.
76. A.Vrieze, E.Van Nood, F.Holleman, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913–916e917.
77. Y.Taur, R.R.Jenq, M.A.Perales, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124(7):1174–1182.
78. E.Holler, P.Butzhammer, K.Schmid, et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(5):640–645.
79. M.Qayed, A.Langston, K.Y.Chiang, et al. Rifaximin for preventing acute graft-versus-host disease: impact on plasma markers of inflammation and T-cell activation. J Pediatr Hematol Oncol. 2013;35(4):e149–152.
80. A.Gerbitz, M.Schultz, A.Wilke, et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood. 2004;103(11):4365–4367.
81. C.G.De CastroJr, A.J.Ganc, R.L.Ganc, et al. Fecal microbiota transplant after hematopoietic SCT: report of a successful case. Bone Marrow Transplant. 2015;50(1):145.
82. E.G.Pamer. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 2014;7(2):210–214.
83. M.S.Goyal, S.Venkatesh, J.Milbrandt, et al. Feeding the brain and nurturing the mind: Linking nutrition and the gut microbiota to brain development. Proc Natl Acad Sci U S A. 2015;112(46):14105–14112.• This paper illustrates the usefulness of modeling metagenomic data for the study of infant microbiota maturation under conditions of undernutrition.
84. M.R.Charbonneau, D.O’Donnell, L.V.Blanton, et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell. 2016;164(5):859–871.
85. S.Subramanian, S.Huq, T.Yatsunenko, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature. 2014;510(7505):417–421.
86. D.Zeevi, T.Korem, N.Zmora, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079–1094.•• This is a landmark paper on the use of metagenomic data for personnalized recommendations pertaining to nutrition and metabolic health.
87. S.Shoaie, P.Ghaffari, P.Kovatcheva-Datchary, et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 2015;22(2):320–331.
88. S.Mondot, P.Lepage, P.Seksik, et al. Structural robustness of the gut mucosal microbiota is associated with Crohn’s disease remission after surgery. Gut. 2015:1–9.
89. S.Viaud, F.Saccheri, G.Mignot, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342(6161):971–976.
90. J.Chun, J.H.Lee, Y.Jung, et al. EzTaxon: a web-based tool for the identification of prokaryotes based on 16S ribosomal RNA gene sequences. Int J Syst Evol Microbiol. 2007;57(Pt 10):2259–2261.• This paper is a showcase for the importance of creating and maintaining well-curated databases.
91. K.S.Park, C.S.Ki, C.I.Kang, et al. Evaluation of the GenBank, EzTaxon, and BIBI services for molecular identification of clinical blood culture isolates that were unidentifiable or misidentified by conventional methods. J Clin Microbiol. 2012;50(5):1792–1795.
92. S.N.Naccache, S.Federman, N.Veeraraghavan, et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 2014;24(7):1180–1192.
93. R.Leinonen, H.Sugawara, M.Shumway. The sequence read archive. Nucleic Acids Res. 2011;39(Database issue):D19–21.
94. A.Henschel, M.Z.Anwar, V.Manohar. Comprehensive meta-analysis of ontology annotated 16S rRNA profiles identifies beta diversity clusters of environmental bacterial communities. PLoS Comput Biol. 2015;11(10):e1004468.
95. I.Lagkouvardos, T.Weinmaier, F.M.Lauro, et al. Integrating metagenomic and amplicon databases to resolve the phylogenetic and ecological diversity of the Chlamydiae. Isme J. 2014;8(1):115–125.•• Papers 82 and 83 are state-of-the-art examples of the potential of large-scale integration of sequencing data for the study of bacterial diversity.
96. T.Yatsunenko, F.E.Rey, M.J.Manary, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227.
97. S.C.Forster, H.P.Browne, N.Kumar, et al. HPMCD: the database of human microbial communities from metagenomic datasets and microbial reference genomes. Nucleic Acids Res. 2016;44(D1):D604–609.
98. T.Clavel, I.Lagkouvardos, M.Blaut, et al. The mouse gut microbiome revisited: from complex diversity to model ecosystems. Int J Med Microbiol. 2016 Mar 5. pii:S1438-4221(16)30017-0. doi:10.1016/j.ijmm.2016.03.002. [Epub ahead of print]
99. P.Hugon, J.C.Lagier, C.Robert, et al. Molecular studies neglect apparently gram-negative populations in the human gut microbiota. J Clin Microbiol. 2013;51(10):3286–3293.
100. A.K.Hawkins, K.C.O’Doherty. “Who owns your poop?”: insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genomics. 2011;4:72.
101. N.Fierer, C.L.Lauber, N.Zhou, et al. Forensic identification using skin bacterial communities. Proc Natl Acad Sci U S A. 2010;107(14):6477–6481.